CorMedix Inc. (CRMD) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cormedix Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:08.037 -- 00:00:13.302 Good morning and welcome to the CORE Medix second quarter 2026 earnings and corporate 00:00:13.302 -- 00:00:15.744 update conference call. 00:00:15.744 -- 00:00:18.846 Today's conference call is being recorded. 00:00:18.846 -- 00:00:23.550 There will be a question and answer session at the end of today's presentation and instructions 00:00:23.550 -- 00:00:27.330 on how to ask a question will be given at that time. 00:00:27.330 -- 00:00:31.732 At this time, I would like to turn the conference call over to Dan Ferry from LifeSci 00:00:31.732 -- 00:00:35.252 Advisors. Please go ahead. 00:00:36.053 -- 00:00:40.355 Good morning, and welcome to the Corps Medics second quarter 2026 earnings and corporate 00:00:40.355 -- 00:00:45.397 update conference call. Leading the call today is Joe Todisco, Chairman and Chief Executive 00:00:45.397 -- 00:00:52.198 Officer of Corps Medics. He is joined by Liz Hurlburt, EVP and Chief Operating and Commercial 00:00:52.379 -- 00:00:57.638 Officer, and Susan Blum, EVP and Chief Financial Officer. 00:00:57.638 -- 00:01:02.862 In addition, Beth Zelnick-Kaufman, EVP and Chief Legal and Compliance Officer and Corporate 00:01:02.862 -- 00:01:07.925 Secretary, and Dr. Matt David, EVP and Chief Business Officer, are on the 00:01:07.925 -- 00:01:12.187 line and will be available during the Q&A session. 00:01:12.188 -- 00:01:16.531 Before we begin, I would like to remind everyone that during the call, management may 00:01:16.531 -- 00:01:21.693 make what are known as forward-looking statements within the meeting set forth in 00:01:30.977 -- 00:01:34.919 Thank you for joining us. 00:01:59.529 -- 00:02:02.991 and investors should not place undue reliance on these statements. 00:02:02.991 -- 00:02:06.794 CoreMedix doe...